Global Artificial Urinary Sphincter Implantation Device Market: Introduction
Artificial urinary sphincter (AUS) implantation is a treatment for refractory stress urinary incontinence (SUI) caused due to the intrinsic sphincter deficiency (ISD). Urinary incontinence (UI) is regarded as a major health issue affecting a large sector of the population. Artificial urinary sphincter (AUS) implantation consists of a hydraulic cuff, which surrounds the urethra or bladder neck. Urinary continence requires the coordinated function of both the bladder and urethra. The cuff is closed most of the time, preventing leakage. When the patient cycles the device, using the pump in the scrotum, the cuff opens up and allows the patient to urinate. Over a minute or so, the cuff refills with fluid, thus causing continence again. The cuff needs to be deactivated so the cuff is not injured. This is typically done by an urologist or experienced physician.
Read Report Overview: https://www.transparencymarketresearch.com/artificial-urinary-sphin...
Key Drivers of Global Artificial Urinary Sphincter Implantation Device Market
Increasing Prevalence of Stress and Urge Urinary Incontinence (UI)
There are two main types of urinary incontinence, one is stress urinary incontinence in which urine leaks in association with physical exertion, and urgency urinary incontinence, in which urine leaks in association with a sudden compelling desire to void. According to the International Urogynecological Association (IUGA) and the International Continence Society (ICS) standard definition, stress incontinence is the complaint of urine leakage in association with coughing, sneezing, or physical exertion, whereas urgency incontinence is the complaint of urine leakage associated with a sudden compelling desire to void that is difficult to defer. These factors are expected to drive the market.
Request Brochure of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B...
Technological Advancements
A newer surgical technique utilizing Argus-T, as a transobturator approach, showed that it appears to be safe and was associated with at least 60% continence rate. The surgical technique on Virtue sling placement was updated in early 2010s with proposed tensioning of the transobturator arm to elevate the bulbous urethra. Several such technological advancements are expected to drive the market during the forecast period.
North America to Account for Major Share of Global Artificial Urinary Sphincter Implantation Device Market
• North America is projected to account for major share of the global artificial urinary sphincter implantation device market during the forecast period. The market in the region is anticipated to grow at a rapid pace in the next few years due to increase of urinary infections. Europe is expected to be the second largest market during the forecast period.
• The artificial urinary sphincter implantation device market in Asia Pacific is likely to expand at a high CAGR during the forecast period. This can be attributed to rise in investment in research & development by the private and government organizations and increasing awareness campaigns by various organizations regarding urinary diseases.
Request for Covid-19 Impact Analysis - https://www.transparencymarketresearch.com/sample/sample.php?flag=c...
Key Players Operating in Global Artificial Urinary Sphincter Implantation Device Market
The global artificial urinary sphincter implantation device market is highly consolidated, with the presence of a small number of key players. Leading players operating in the global artificial urinary sphincter implantation device market include:
• Boston Scientific Inc.
• GT Urological
• RBM-Med
• ZEPHYR Surgical Implants
• Albyn Medical, Ltd.
• Andromeda Medizinische Systeme Gmbh
• Cook Urological, Inc.
• Coopersurgical, Inc.
• Laborie Medical Technologies, Inc
• Silimed
• Gt Urological